Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Current Leases (2022 - 2025)

Praxis Precision Medicines has reported Current Leases over the past 4 years, most recently at $110000.0 for Q4 2025.

  • Quarterly results put Current Leases at $110000.0 for Q4 2025, down 91.26% from a year ago — trailing twelve months through Dec 2025 was $110000.0 (down 91.26% YoY), and the annual figure for FY2025 was $110000.0, down 91.26%.
  • Current Leases for Q4 2025 was $110000.0 at Praxis Precision Medicines, down from $436000.0 in the prior quarter.
  • Over the last five years, Current Leases for PRAX hit a ceiling of $1.3 million in Q4 2024 and a floor of $110000.0 in Q4 2025.
  • Median Current Leases over the past 4 years was $1.0 million (2023), compared with a mean of $967187.5.
  • Biggest five-year swings in Current Leases: rose 12.12% in 2023 and later plummeted 91.26% in 2025.
  • Praxis Precision Medicines' Current Leases stood at $1.0 million in 2022, then grew by 12.04% to $1.1 million in 2023, then rose by 11.81% to $1.3 million in 2024, then plummeted by 91.26% to $110000.0 in 2025.
  • The last three reported values for Current Leases were $110000.0 (Q4 2025), $436000.0 (Q3 2025), and $755000.0 (Q2 2025) per Business Quant data.